InsiderClue
Insiders · Profile

Champoux Jennifer

Chief Operating Officer at Monte Rosa Therapeutics. Filing since 5 Jan 2026. CIK 0002025233

Company
Date
Role
Action
Shares
Amount
Of holding
GLUE Monte Rosa Therapeutics, Inc.
15 Jul 2026
Chief Operating Officer
Sold on a plan
4,351
$101.73K
6.5%
GLUE Monte Rosa Therapeutics, Inc.
23 Jun 2026
Chief Operating Officer
Sold on a plan
2,175
$43.50K
3.4%
GLUE Monte Rosa Therapeutics, Inc.
17 Jun 2026
Chief Operating Officer
Sold on a plan
2,176
$41.34K
3.4%
GLUE Monte Rosa Therapeutics, Inc.
27 May 2026
Chief Operating Officer
Sold on a plan
2,175
$43.50K
3.4%
GLUE Monte Rosa Therapeutics, Inc.
22 May 2026
Chief Operating Officer
Sold on a plan
2,176
$41.34K
3.4%
GLUE Monte Rosa Therapeutics, Inc.
5 Jan 2026
Chief Operating Officer
Sold at will
2,629
$39.88K
4.0%
6 decisions on file.